Medicare Can Cover Anti-Obesity Drugs for Heart Disease — But at What Cost?

by iMARS Staff 08. April 2024 Health 0

(MedPage Today) — On March 8, 2024, FDA approved Wegovy (semaglutide) to treat cardiovascular disease risks — heart attack, stroke, and death — for obese or overweight adults with a history of cardiovascular disease, making it the first…